Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Polycystic kidney disease surgery

Introduction

Overview

Overview

Surgery is not the first-line treatment option for patients with polycystic kidney disease. Surgery is usually reserved for patients with either end stage renal disease (ESRD), recurrent UTI, chronic pain, renal cell carcinoma, chronic hematuria requiring transfusions. Surgical options are either nephrectomy or renal transplantation.

Indications

Indications

Surgery is not the first-line treatment option for patients with polycystic kidney disease. Surgery is usually reserved for patients with either:[1][2][3]

Surgery

Surgery

Contraindications

Contraindications

References

References

  1. ↑ Hadimeri H, Nordén G, Friman S, Nyberg G (July 1997). “Autosomal dominant polycystic kidney disease in a kidney transplant population”. Nephrol. Dial. Transplant. 12 (7): 1431–6. PMID 9249781.
  2. ↑ Glassman DT, Nipkow L, Bartlett ST, Jacobs SC (September 2000). “Bilateral nephrectomy with concomitant renal graft transplantation for autosomal dominant polycystic kidney disease”. J. Urol. 164 (3 Pt 1): 661–4. PMID 10953121.
  3. ↑ Fuller TF, Brennan TV, Feng S, Kang SM, Stock PG, Freise CE (December 2005). “End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation”. J. Urol. 174 (6): 2284–8. doi:10.1097/01.ju.0000181208.06507.aa. PMID 16280813.
  4. ↑ Torres VE, Harris PC (July 2009). “Autosomal dominant polycystic kidney disease: the last 3 years”. Kidney Int. 76 (2): 149–68. doi:10.1038/ki.2009.128. PMC 2812475. PMID 19455193.
  5. ↑ Ring T, Spiegelhalter D (December 2007). “Risk of intracranial aneurysm bleeding in autosomal-dominant polycystic kidney disease”. Kidney Int. 72 (11): 1400–2. doi:10.1038/sj.ki.5002488. PMID 17882153.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]